Docetaxel

Contraindicated

Docetaxel Bacillus Of Calmette And Guerin Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Dengue Tetravalent Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Ensitrelvir Increased CYP3A substrates exposure and an increased risk of CYP3A substrates-related adverse effects Details Docetaxel Levoketoconazole Recorlev Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Docetaxel Measles Virus Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Mifepristone Korlym Increased CYP3A4 substrate with NTI exposure Details Docetaxel Mumps Virus Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Rubella Virus Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Smallpox Monkeypox Vaccine An increased risk of infection by the live vaccine Details Docetaxel Typhoid Vaccine Typhim VI® An increased risk of infection by the live vaccine Details Docetaxel Varicella Virus Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Yellow Fever Vaccine Stamaril An increased risk of infection by the live vaccine Details

Major

Docetaxel Abametapir Increased exposure of CYP3A4 substrate Details Docetaxel Asciminib Scemblix Increased CYP3A4 exposure and an increased risk of CYP3A4-related adverse reactions Details Docetaxel Belumosudil Rezurock Increased OATP1B1 substrate exposure Details Docetaxel Darolutamide Nubeqa Increased exposure of OATP1B1 or OATP1B3 substrates Details Docetaxel Adagrasib Krazati Increased DOCEtaxel exposure Details Docetaxel Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Docetaxel Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Docetaxel Amiodarone Nexterone Increase in docetaxel exposure and risk of toxicity Details Docetaxel Apalutamide Erleada Reduced OATP1B1/CYP3A4 substrate exposure Details Docetaxel Aprepitant Aponvie Increased chemotherapeutic agent exposure Details Docetaxel Atazanavir Reyataz An increased risk of DOCEtaxel exposure Details Docetaxel Avacopan Tavneos Increased exposure to CYP3A4 substrate Details Docetaxel Belzutifan Welireg Reduced CYP3A4 substrates with NTI exposure and reduced efficacy of CYP3A4 substrates with NTI Details Docetaxel Berotralstat Orladeyo Increased CYP3A4 substrate exposure and an increased CYP3A4 substrate-related adverse reactions Details Docetaxel Boceprevir Increased DOCEtaxel exposure Details Docetaxel Carbamazepine Carbatrol Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Docetaxel Ceritinib Zykadia Increased exposure of CYP3A substrate Details Docetaxel Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Docetaxel Clarithromycin Biaxin Increased DOCEtaxel exposure Details Docetaxel Cobicistat Tybost Increased DOCEtaxel exposure Details Docetaxel Conivaptan Vaprisol Increased CYP3A substrate exposure Details Docetaxel Crizotinib Xalkori Increased exposure of the CYP3A substrate Details Docetaxel Daridorexant Increased CYP3A4 substrate with NTI exposure Details Docetaxel Dronedarone Multaq An increased exposure to docetaxel Details Docetaxel Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Docetaxel Elexacaftor Increased OATP1B1/OATP1B3 substrate exposure Details Docetaxel Elinzanetant Lynkuet Increased CYP3A4 substrate with NTI exposure and an increased CYP3A4 substrate with NTI-related adverse reactions Details Docetaxel Eltrombopag Alvaiz Increased OATP1B1 substrates exposure and an increased risk of OATP1B1 substrates-related adverse reactions Details